• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

接受房间隔分流装置植入术治疗射血分数保留心力衰竭的患者的长期随访。

Long-term follow-up of a patient undergoing interatrial shunt device implantation for treatment of heart failure with a preserved ejection fraction.

机构信息

Cardiology Fellow, Department of Cardiology, Na Homolce Hospital Cardiovascular Center, Roentgenova 2, 150 30, Prague 5, Czech Republic.

Head of Department of Cardiology, Na Homolce Hospital Cardiovascular Center, Roentgenova 2, 150 30, Prague 5, Czech Republic.

出版信息

J Int Med Res. 2022 May;50(5):3000605221098178. doi: 10.1177/03000605221098178.

DOI:10.1177/03000605221098178
PMID:35615787
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9152196/
Abstract

We herein present a case study of a patient with heart failure with a preserved ejection fraction and severe symptoms who underwent interatrial shunt device implantation and follow-up at a tertiary care heart failure clinic. The interatrial shunt device implantation was successful. No adverse events occurred, and the device prevented hospitalization for heart failure during long-term follow-up.

摘要

我们在此报告了一例心力衰竭伴射血分数保留和严重症状的患者，该患者在三级心力衰竭诊所接受了房间隔分流装置植入术和随访。房间隔分流装置植入术成功。在长期随访中，未发生不良事件，且该装置预防了心力衰竭住院。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39c3/9152196/84f03fea8b6d/10.1177_03000605221098178-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39c3/9152196/3720d952a7ca/10.1177_03000605221098178-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39c3/9152196/84f03fea8b6d/10.1177_03000605221098178-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39c3/9152196/3720d952a7ca/10.1177_03000605221098178-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39c3/9152196/84f03fea8b6d/10.1177_03000605221098178-fig2.jpg

相似文献

1
Long-term follow-up of a patient undergoing interatrial shunt device implantation for treatment of heart failure with a preserved ejection fraction.接受房间隔分流装置植入术治疗射血分数保留心力衰竭的患者的长期随访。
J Int Med Res. 2022 May;50(5):3000605221098178. doi: 10.1177/03000605221098178.
2
Impact of an interatrial shunt device on survival and heart failure hospitalization in patients with preserved ejection fraction.房间隔分流装置对射血分数保留心力衰竭患者生存和心力衰竭住院的影响。
ESC Heart Fail. 2019 Feb;6(1):62-69. doi: 10.1002/ehf2.12350. Epub 2018 Oct 11.
3
InterAtrial Shunt Device (IASD®) implantation - a novel treatment method for heart failure with preserved ejection fraction.房间隔分流装置（IASD®）植入术——一种治疗射血分数保留的心力衰竭的新方法。
Kardiol Pol. 2017;75(8):736-741. doi: 10.5603/KP.a2017.0096. Epub 2017 May 25.
4
One-Year Outcomes After Transcatheter Insertion of an Interatrial Shunt Device for the Management of Heart Failure With Preserved Ejection Fraction.经导管插入房间隔分流装置治疗射血分数保留的心力衰竭的一年结局
Circ Heart Fail. 2016 Dec;9(12):e003662. doi: 10.1161/CIRCHEARTFAILURE.116.003662.
5
One-Year Safety and Clinical Outcomes of a Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure With Preserved Ejection Fraction in the Reduce Elevated Left Atrial Pressure in Patients With Heart Failure (REDUCE LAP-HF I) Trial: A Randomized Clinical Trial.经导管房间隔分流装置治疗射血分数保留心力衰竭的一年安全性和临床结局：降低心力衰竭患者左心房压力（REDUCE LAP-HF I）试验：一项随机临床试验。
JAMA Cardiol. 2018 Oct 1;3(10):968-977. doi: 10.1001/jamacardio.2018.2936.
6
Rationale and Design of the Reduce Elevated Left Atrial Pressure in Patients With Heart Failure (Reduce LAP-HF) Trial.心力衰竭患者降低升高的左心房压力（Reduce LAP-HF）试验的原理与设计
J Card Fail. 2015 Jul;21(7):594-600. doi: 10.1016/j.cardfail.2015.05.008. Epub 2015 Jun 6.
7
Atrial shunt device for heart failure with preserved and mildly reduced ejection fraction (REDUCE LAP-HF II): a randomised, multicentre, blinded, sham-controlled trial.用于射血分数保留和轻度降低的心力衰竭的心房分流装置（REDUCE LAP-HF II）：一项随机、多中心、双盲、假对照试验。
Lancet. 2022 Mar 19;399(10330):1130-1140. doi: 10.1016/S0140-6736(22)00016-2. Epub 2022 Feb 1.
8
Interatrial Shunt Devices.房间隔分流装置
Heart Fail Clin. 2024 Jan;20(1):61-69. doi: 10.1016/j.hfc.2023.05.003. Epub 2023 Jul 4.
9
Interatrial Shunting for Heart Failure: Early and Late Results From the First-in-Human Experience With the V-Wave System.房间隔分流术治疗心力衰竭：首例 V-Wave 系统人体试验的早期和晚期结果。
JACC Cardiovasc Interv. 2018 Nov 26;11(22):2300-2310. doi: 10.1016/j.jcin.2018.07.001. Epub 2018 Nov 1.
10
Interatrial Shunting, a Novel Device-Based Therapy for Patients With Heart Failure.房间隔分流术，一种针对心力衰竭患者的新型基于器械的治疗方法。
Cardiol Rev. 2018 Sep/Oct;26(5):267-273. doi: 10.1097/CRD.0000000000000199.

引用本文的文献

1
Atrial Shunt Therapy for Heart Failure: An Update.心力衰竭的心房分流治疗：最新进展
J Soc Cardiovasc Angiogr Interv. 2023 Dec 4;2(6Part B):101203. doi: 10.1016/j.jscai.2023.101203. eCollection 2023 Nov-Dec.
2
Left atrial appendage closure in a patient previously implanted with an interatrial shunt device: a case report.患者曾植入房间隔分流装置，现行左心耳封堵术：病例报告。
BMC Cardiovasc Disord. 2024 Jun 6;24(1):293. doi: 10.1186/s12872-024-03904-0.

本文引用的文献

1
One-Year Safety and Clinical Outcomes of a Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure With Preserved Ejection Fraction in the Reduce Elevated Left Atrial Pressure in Patients With Heart Failure (REDUCE LAP-HF I) Trial: A Randomized Clinical Trial.经导管房间隔分流装置治疗射血分数保留心力衰竭的一年安全性和临床结局：降低心力衰竭患者左心房压力（REDUCE LAP-HF I）试验：一项随机临床试验。
JAMA Cardiol. 2018 Oct 1;3(10):968-977. doi: 10.1001/jamacardio.2018.2936.
2
A transcatheter intracardiac shunt device for heart failure with preserved ejection fraction (REDUCE LAP-HF): a multicentre, open-label, single-arm, phase 1 trial.经导管左心室内分流装置治疗射血分数保留的心力衰竭（REDUCE LAP-HF）：一项多中心、开放标签、单臂、1 期试验。
Lancet. 2016 Mar 26;387(10025):1298-304. doi: 10.1016/S0140-6736(16)00704-2.
3
Transcatheter treatment of heart failure with preserved or mildly reduced ejection fraction using a novel interatrial implant to lower left atrial pressure.经导管治疗射血分数保留或轻度降低的心衰：使用新型房间隔植入物降低左心房压力。
Eur J Heart Fail. 2014 Jul;16(7):796-801. doi: 10.1002/ejhf.111. Epub 2014 Jun 24.
4
The CARE guidelines: consensus-based clinical case reporting guideline development.CARE 指南：基于共识的临床病例报告指南制定。
Headache. 2013 Nov-Dec;53(10):1541-7. doi: 10.1111/head.12246.
5
Predicting survival in heart failure: a risk score based on 39 372 patients from 30 studies.预测心力衰竭患者的生存情况：基于 30 项研究的 39372 例患者的风险评分。
Eur Heart J. 2013 May;34(19):1404-13. doi: 10.1093/eurheartj/ehs337. Epub 2012 Oct 24.